Is Ibnsina Pharma Co SAE halal to invest in?

According to Musaffa's Shariah screening methodology, Ibnsina Pharma Co SAE (ISPH.CA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Ibnsina Pharma Co SAE a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ibnsina Pharma Co SAE using these criteria to determine its compliance status.

Can Muslims buy shares of Ibnsina Pharma Co SAE?

Muslim investors may consider investing in Ibnsina Pharma Co SAE if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Ibnsina Pharma Co SAE classified as NOT HALAL?

Musaffa determines the Shariah status of Ibnsina Pharma Co SAE by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Ibnsina Pharma Co SAE updated?

The Shariah compliance status of Ibnsina Pharma Co SAE may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Ibnsina Pharma Co SAE become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Ibnsina Pharma Co SAE?

You can check the latest Shariah compliance status of Ibnsina Pharma Co SAE on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ISPH.CA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 17, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Ibnsina Pharma Co SAE (ISPH.CA)

Based on 9 analysts giving stock ratings to Ibnsina Pharma Co SAE in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Ibnsina Pharma Co SAE. Stock Analysis ISPH.CA

Egypt Health Care Micro Cap Report: 2025 Annual

Ibnsina Pharma engages in storage, supply and distribution of pharmaceutical & cosmetic products. The firm distributes a portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers. Ibnsina Pharma Co's nationwide distribution network with more than 50 operational sites, including distribution hubs and central warehouses, is supported by a fleet of approximately 600 vehicles. The firm's main services for suppliers include management of warehousing and logistics for pharmaceutical products as well as the development and execution of tailored marketing solutions targeting a nationwide database of customers.

Key Statistics of Ibnsina Pharma Co SAE (ISPH.CA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

EGP11.65EGP12.04

Today's Open

EGP11.99

Volume

9.39M

P/E Ratio (TTM)

13.82

52 Week Range

EGP8.17EGP13.72

Market Cap

12.32B

Avg. Volume

11.72M

Dividend Yield

1.53%

Financial Metrics & Statements of Ibnsina Pharma Co SAE (ISPH.CA)

FAQ's for Ibnsina Pharma Co SAE (ISPH.CA)

According to Musaffa’s Shariah screening methodology, Ibnsina Pharma Co SAE (ISPH.CA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.